je.st
news
Tag: treatment
Merck Announces European Medicines Agency Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection
2015-07-23 17:02:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1, 3, 4 or 6 infection.1 The EMA will initiate review of the MAA under accelerated assessment timelines. Language: English Contact: Merck & Co., Inc.Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
application
marketing
treatment
Variable Wastewater Flows No Match For Fixed-Film Treatment System
2015-07-23 12:59:14| metrologyworld Home Page
Fed up with a wastewater treatment system poorly equipped to deal with variable flow conditions, one retreat and camp facility thought FAST® and found a more effective and operator-friendly solution. The Bishop Hodges Pastoral Center is a year-round West Virginia recreational facility known for hosting camps, business meetings and other social events. From week- to- week, or even day-to-day, the number of people on the property can vary significantly. The FAST® Wastewater Treatment System by Smith & Loveless is perfect for these variable flow conditions. Learn how this facility uses the FAST® to treat their wastewater - low or high flow.
Tags: system
match
treatment
variable
Emergent BioSolutions manufacturing Ebola treatment in Baltimore
2015-07-20 17:36:33| Biotech - Topix.net
Gaithersburg biotechnology company Emergent BioSolutions will make a treatment for the Ebola virus at its East Baltimore manufacturing facility, the company said Monday. The defense department's Biomedical Advanced Research and Development Authority is paying Emergent $19.7 million to manufacture Ebola monoclonal antibodies.
Tags: treatment
manufacturing
baltimore
emergent
Peoples' Choice: Manure treatment Sulfi-Doxx is popular with WPE '15 visitors
2015-07-15 18:15:00| National Hog Farmer
By Willie Vogt, correspondent Sulfi-Doxx Black Magic from Direct Biologicals in Yankton, S.D., was the favorite item on New Product Tour among World Pork Expo visitors. read more
Tags: popular
choice
treatment
visitors
atg UV Technology-UV Treatment Equipment for the Oil and Gas Sector
2015-07-14 13:04:00| Offshore Technology
atg UV Technology are the worlds' only UV manufacturer to specialise in ultraviolet (UV) treatment systems and integrated technology packages for the oil and gas industry. atg UV Technology has more ...
Tags: equipment
treatment
gas
oil
Sites : [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] next »